Abstract
Alzheimer’s disease (AD) is the most common form of dementia, characterized by neurovascular dysfunction, elevated brain parenchymal and vascular amyloid-β (Aβ) levels, tau pathology, and neuronal loss (1, 2). Faulty transvascular clearance of brain Aβ across the blood–brain barrier (BBB) plays an important role in Aβ accumulation in the brain, both in human AD and animal models (1⇓⇓–4). Normally, transvascular brain-to-blood transport across the BBB clears most of Aβ from brain (∼85%), whereas the interstitial fluid (ISF) bulk flow along perivascular spaces removes the remaining smaller fraction of ∼15% of Aβ (5). The two major apolipoproteins in brain, apolipoprotein E (APOE) and apolipoprotein J (APOJ), also known as clusterin (CLU), interact with Aβ and regulate its clearance from brain (1, 2) (Fig. 1). Specifically, Aβ is cleared across the BBB as a free peptide and/or bound to apolipoproteins E2 and E3, but not E4, via endothelial low-density lipoprotein receptor-related protein 1 (LRP1), whereas CLU binds Aβ and mediates its clearance across the BBB via low-density lipoprotein-related protein 2 (LRP2; also known as megalin and gp330) (2, 4). Peripheral Aβ reenters the brain by the receptor for advanced glycation end products (RAGE) (6). In PNAS, Wojtas et al. (7) explore the effect of endogenous murine Clu deficiency on Aβ pathology. The neurovascular unit includes neurons, astrocytes, mural cells, and endothelial cells. The type of mural cell varies along the vascular tree, with smooth muscle cells circumventing arteries and arterioles, …
Funding Information
  • HHS | NIH | National Institute on Aging (P50AG005142, R01AG023084, P01AG052350, RO1NS100459)
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS034467, R01NS090904)
  • Fondation Leducq (Fondation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small V)
  • Alzheimer's Association (509279)

This publication has 23 references indexed in Scilit: